Efforts are targeting areas believed to be contributors or key drivers of the challenged subspecialty workforce, including ...

Researchers at the Icahn School of Medicine at Mount Sinai have uncovered a new way to understand how children fare after ...

This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical ...

Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to survive ...

Researchers at the Icahn School of Medicine at Mount Sinai have uncovered a new way to understand how children fare after ...

Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to surviveGroundbreaking PS redu ...

Palmer Harper, 13, relies on infusions at Christus and a child life specialist who helps support her during that process.

Therapeutic drug monitoring is associated with better treatment durability among children with inflammatory bowel diseases.

Inflammatory bowel disease (IBD) in children and adolescents represents a rapidly growing field of research within pediatric gastroenterology. Over the past ...

Crofelemer can potentially extend lives of MVID patients – infants and children who face the lethal natural history of the disease Parenteral support reduction of up to 37% is groundbreaking; No ...

Among pediatric patients with hereditary angioedema, on-demand sebetralstat was generally safe and used within a median time of 30 minutes after attack onset, according to interim phase 3 trial ...

OU Health’s Dr. Max Brookman shares how to spot reactions and when to get emergency care as families gather for holiday meals ...